Isi Artikel Utama

Linda Purnamawati Suherman
https://orcid.org/0000-0003-2578-4721
Diana Novalina
Pudjiastuti Kartidjo
Fauziah Nurul Afifah

Page: 1628-1636

Abstrak

Diabetes melitus tipe 2 (DMT2) dengan komplikasi hipertensi membutuhkan penatalaksanaan farmakologis yang rasional dan terstandarisasi guna mencegah perburukan kardiovaskular. Penelitian ini bertujuan mengevaluasi pola dan tingkat rasionalitas penggunaan obat antidiabetes pada pasien DMT2 dengan komplikasi hipertensi di instalasi rawat inap salah satu rumah sakit di Kota Cimahi periode Januari 2023–Desember 2024. Penelitian ini menggunakan desain observasional deskriptif-analitik retrospektif terhadap 79 data rekam medis yang memenuhi kriteria inklusi. Penilaian rasionalitas diukur menggunakan lima parameter berdasarkan pedoman Kemenkes RI yaitu tepat indikasi, pemilihan obat, dosis, interval waktu pemberian, dan lama terapi. Mayoritas pasien adalah lansia perempuan (62%). Pola peresepan menunjukkan 50,6% pasien menerima terapi kombinasi insulin dan obat hipoglikemik oral (OHO), 31,7% monoterapi OHO, dan 12,6% monoterapi insulin, dengan metformin dan glimepiride sebagai OHO terbanyak. Hasil evaluasi tingkat kerasionalan mencapai 100% pada parameter tepat indikasi dan lama pemberian, 96% pada tepat interval waktu, 90% pada tepat dosis, dan 70% pada tepat pemilihan obat. Ketidaktepatan mayoritas bersumber dari pemilihan regimen insulin yang belum diindividualisasi secara optimal terhadap profil klinis pasien. Secara keseluruhan, penatalaksanaan antidiabetes tergolong rasional, namun pendekatan multidisiplin dan koordinasi yang kuat antara dokter dan apoteker klinis sangat diperlukan untuk mengoptimalkan individualisasi terapi dan kepatuhan terhadap pedoman standar

Unduhan

Data unduhan belum tersedia.

Rincian Artikel

Cara Mengutip
Suherman , L. P., Novalina , D., Kartidjo , P., & Afifah , F. N. (2026). Evaluasi Rasionalitas Penggunaan Obat Antidiabetes pada Pasien Diabetes Melitus Tipe 2 dengan Komplikasi Hipertensi di Instalasi Rawat Inap Salah Satu Rumah Sakit Kota Cimahi: English. Journal of Pharmaceutical and Sciences, 9(2), 1628–1636. https://doi.org/10.36490/journal-jps.com.v9i2.1501
Bagian
Original Articles
Biografi Penulis

Linda Purnamawati Suherman , Universitas Jenderal Achmad Yani

Faculty of Pharmacy

Diana Novalina , Universitas Jenderal Achmad Yani

Faculty of Pharmacy

Referensi

Trusda SAD, Purbaningsih W, Budiman B, Fitriadi SSN. Characteristics of Patients with Type 2 Diabetes Mellitus in Al-Ihsan Regional General Hospital. Global Medical and Health Communication (GMHC) 2021;9:150–7. https://doi.org/10.29313/gmhc.v9i2.8123. DOI: https://doi.org/10.29313/gmhc.v9i2.8123

Nur Aeni S, Yulinah Sukandar E, Hermanto F. Study of Drug Interactions in Diabetes Patients at Several Hospitals in Indonesia. Jurnal Ilmiah Farmasi 2024;4:204–18. https://doi.org/10.36805/jbf.v4i3.1123. DOI: https://doi.org/10.36805/jbf.v4i3.1123

Salma Dhiya A, Karjatin A, Terapan S, Kesehatan P, Kesehatan P, Bandung K. Interactive Educational Website Media for the Prevention of Type 2 Diabetes Mellitus at SMAN 4 Cimahi. Jurnal Kesehatan Siliwangi 2024;5:15–25. https://doi.org/10.34011/jks.v5i1.2453. DOI: https://doi.org/10.34011/jks.00.2453

Julaeha J, Fudjiati E, Eff ARY. Assessment of Drug Therapy Problems Among Type 2 Diabetes Patients with Hypertension Comorbidity in Indonesia. Borneo Journal of Pharmacy 2020;3:190–8. https://doi.org/10.33084/bjop.v3i3.1359. DOI: https://doi.org/10.33084/bjop.v3i3.1359

Natanael J, Damayanti E, Himayani R. Literature Review: Study of Potential Antidiabetic Drug Interactions in Type 2 Diabetes Mellitus Patients with Hypertension Complications. Sains Medisina 2024;2:201–6. https://doi.org/https://doi.org/10.63004/snsmed.v2i6.468. DOI: https://doi.org/10.63004/snsmed.v2i6.468

Alexander T, Hiremath JS, Swahney JPS, Chandra S, Jain P, Chandra P, et al. Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India. J Clin Hypertens 2025;27. https://doi.org/10.1111/jch.14963. DOI: https://doi.org/10.1111/jch.14963

Adi Ismaya N, Dwi Pratiwi R, Purnama Sari Indah F, Azzahra E. Evaluation of Antidiabetic Medication Use in Diabetes Mellitus Patients with Hypertension Complications at UIN Syarif Hidayatullah Hospital. Edu Masda Journal 2024;08:72–86. https://doi.org/10.52118/edumasda.v8i1.214. DOI: https://doi.org/10.52118/edumasda.v8i1.214

Andriyani R, Fortuna TA. Evaluation of the Use of Antihypertension Drugs and The Success of Antihypertension Therapy in Hypertension Patients with Diabetes Mellitus in The Outpatient Installation of Dr. Moewardi In 2021. Usadha: Journal of Pharmacy 2023;2:341–60. https://doi.org/https://doi.org/10.23917/ujp.v2i3.108. DOI: https://doi.org/10.23917/ujp.v2i3.108

PERKENI. Guidelines for the Management and Prevention of Type 2 Diabetes Mellitus in Indonesia. PB PERKENI; 2021.

Ministry of Health of the Republic of Indonesia. Guidelines for Pharmaceutical Services in Diabetes Mellitus. 2019.

Masiani WO, Fauziah R, Hanafi LOA. Analysis of the Effectiveness of Oral Antidiabetic Drug Use in Type 2 Diabetes Mellitus Patients at the Inpatient Unit of Kendari City Hospital in 2021. Jurnal Pharmacia Mandala Waluya 2024;3:87–99. https://doi.org/10.54883/jpmw.v3i2.99. DOI: https://doi.org/10.54883/jpmw.v3i2.99

Puspita D, Fauziah F, Samodra G. Cost-effectiveness analysis of metformin and glimepiride therapy in patients with type 2 diabetes mellitus at cilongok i health center. Health and Biological Science ICHBS 2024;1:44–53.

Apriliany F, Cholisah E, Erlianti K. Effect of metformin and metformin+glimepiride on outcome HbA1c in type 2 diabetes mellitus. Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice) 2022;12:97. https://doi.org/10.22146/jmpf.72192. DOI: https://doi.org/10.22146/jmpf.72192

Prasanna Kumar K, Seshadri K, Aravind S, Deb P, Modi K, Gopal RA, et al. Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience. Cureus 2021. https://doi.org/10.7759/cureus.13020. DOI: https://doi.org/10.7759/cureus.13020

Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2022;45:2753–86. https://doi.org/10.2337/dci22-0034. DOI: https://doi.org/10.2337/dci22-0034

ADA. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024. Diabetes Care 2024;47:S20–42. https://doi.org/10.2337/dc24-S002. DOI: https://doi.org/10.2337/dc24-S002

Triplitt C, Repas T, Alvarez C. Pharmacotherapy: A Pathophysiologic Approach. In: DiPiro JT, Yee GC, Posey L, et al., editors. Diabetes Mellitus. 11th ed., New York: McGraw-Hill Education; 2020.

Malihah D, Emelia R, Kesehatan F, Piksi P, Bandung G. Treatment Pattern of Antidiabetic Drugs Use One Type II Diabetes Mellitus Patients at RSAU dr. M. Salamun. Jurnal Delima Harapan 2022;9:83–94. https://doi.org/10.31935/delima.v9i1.161. DOI: https://doi.org/10.31935/delima.v9i1.161

American Diabetes Association Professional Practice Committee. 13. Older Adults: Standards of Care in Diabetes—2024. Diabetes Care 2024;47:S244–57. https://doi.org/10.2337/dc24-S013. DOI: https://doi.org/10.2337/dc24-S013

Graham Gibraltar Sihombing A, Author C, Pendidikan Dokter P, Kedokteran F, Lampung U. Rationale for Type II Diabetes Mellitus Treatment. Jurnal Medika Hutama 2022;3:2175–9.

Syifannisa R, Muthoharoh A, Ningrum WA, Rahmatullah S, Studi P, Farmasi S, et al. Pharmacist Counseling Improves Medication Compliance and Lowers Blood Sugar Levels in Type 2 DM Patients. Jurnal Ilmiah Kesehatan 2022;15:93–102. DOI: https://doi.org/10.48144/jiks.v15i2.1127

Normila N, Soemarie YB, Ramadhani J. Rasionality of Drug Use in Patients with Type II Diabetes Mellitus at The Martapura City Health Center in 2023. Journal of Islamic Pharmacy 2025;10:45–9. https://doi.org/10.18860/jip.v10i1.32341. DOI: https://doi.org/10.18860/jip.v10i1.32341